| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 0.80▼ | 0.78▲ | 0.78▲ | 0.67▲ | 1.30▼ |
| MA10 | 0.79▲ | 0.72▲ | 0.69▲ | 1.07▼ | 1.64▼ |
| MA20 | 0.73▲ | 0.63▲ | 0.65▲ | 1.39▼ | N/A |
| MA50 | 0.61▲ | 0.68▲ | 0.98▼ | 1.79▼ | N/A |
| MA100 | 0.63▲ | 1.13▼ | 1.33▼ | N/A | N/A |
| MA200 | 0.94▼ | 1.41▼ | 1.54▼ | N/A | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.004▲ | 0.034▲ | 0.052▲ | -0.072▼ | N/A |
| RSI | 69.013▲ | 67.004▲ | 54.271▲ | 29.928▼ | N/A |
| STOCH | 75.669 | 93.324▲ | 94.973▲ | 3.626▼ | N/A |
| WILL %R | -21.517▲ | -9.365▲ | -8.338▲ | -90.288▼ | -90.288▼ |
| CCI | 59.534 | 104.982▲ | 111.648▲ | -68.589 | -158.610▼ |
|
Wednesday, November 11, 2026 11:30 PM
(Nasdaq: CNSY) (“Cerenome” or the “Company”), a CNS oncology company integrating diagnostics, therapeutics, and artificial intelligence, today announced it will host a conference call on Monday, ...
|
|
Monday, November 09, 2026 11:30 PM
In his new role, Mr. Andrews will focus on advancing Cerenome’s business development and commercial strategy, with an emphasis on expanding adoption of the CNSide ® Diagnostics platform and developing ...
|
|
Wednesday, November 04, 2026 04:30 AM
Cerenome now contracted with approximately 85% of private payers in the US, representing approximately 190 million covered lives First national CNSide payer agreement to include both tumor cell ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 11/11/26 | 0.705 | 0.9015 | 0.68 | 0.801 | 361,183 |
| 10/11/26 | 0.56 | 0.69 | 0.43 | 0.68 | 1,152,700 |
| 09/11/26 | 0.67 | 0.67 | 0.565 | 0.5698 | 523,051 |
| 06/11/26 | 0.66 | 0.69 | 0.60 | 0.64 | 508,900 |
| 05/11/26 | 0.87 | 0.87 | 0.63 | 0.6699 | 1,135,357 |
| 04/11/26 | 1.28 | 1.28 | 0.78 | 0.89 | 2,413,700 |
| 03/11/26 | 1.70 | 4.25 | 1.16 | 1.30 | 28,706,349 |
| 02/11/26 | 1.74 | 1.83 | 1.70 | 1.71 | 51,899 |
| 30/10/26 | 1.76 | 1.76 | 1.66 | 1.70 | 47,737 |
| 29/10/26 | 1.76 | 1.8382 | 1.70 | 1.74 | 38,749 |
|
|
||||
|
|
||||
|
|